Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Cepharanthine shows promise as a COVID-19 treatment.

Five FDA-approved drugs may help block COVID-19 virus entry.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Ixekizumab has known and some unexpected side effects.

A rare case of a transplant patient developing a skin condition linked to HPV-49.

34% of patients on hepatitis C treatment had reversible skin issues.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

Vimentin and keratin help viruses spread and could be targets for antiviral treatments.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

A new delivery system makes Curcumin more effective and safer against viruses.

Five FDA-approved drugs may help block COVID-19 virus entry.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

A blood pressure drug, diltiazem, may also help treat influenza.

Early diagnosis and treatment of Kaposi varicelliform eruption are crucial to prevent severe complications.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.